TrophAmine Articles
J&J 1st qtr hit by market drop; keeps guidance
15 April 2009
SCLC drug market wil more than double to $648M in 2017
14 April 2009
CyDex Pharma IP to be auctioned
8 April 2009
Zosano patch equivalent to Lilly's Forteo
8 April 2009
Hospira debuts generic Tazocin in UK
7 April 2009
Altea in Lilly/Amylin deal for diabetes patch
7 April 2009
ReNeuron reports positive early data with CTX in PAD
6 April 2009
Celgene falls up to 17% on low 1st-qtr forecast
3 April 2009
Spectrum's 2008 loss halves to $15.5M
3 April 2009
Welsh investment in Ocelus drug-delivery
30 March 2009
Amylin up 8% as Byetta cleared of CV health risk
27 March 2009
FDA declines to review Teva's Citizen Petition
27 March 2009
FDA accepts Fusilev sNDA for mCRC
27 March 2009
Elevated CYP24 expression linked to CKD
23 March 2009
Vetter Pharma sets up new subsidiary
23 March 2009
Endo files response for Nebido application
23 March 2009
NICE gives nod to Bayer's Xarelto
16 March 2009
Akron merges with ApliChem
16 March 2009
FDA asks for more data on Genasense
16 March 2009
TissueGene gets go-ahead for Ph IIa OA trial
16 March 2009
Ferring launches degarelix in USA
9 March 2009
FDA orders boxed warning on metaclopramide
9 March 2009
Sanofi's Apidra SoloSTAR cleared in the USA
9 March 2009
Four Novartis drugs and B-MS
9 March 2009
Archimedes reports strong data for IN drugs
2 March 2009
Ph II trial of TB-402 starts enrolling
2 March 2009
Alk-Abello's Grazax for children launched in UK
2 March 2009
Sanofi launches Apidra in Canada
2 March 2009
Analysts expect profit for Theravance in 2012
2 March 2009
Wakamoto develops diabetic retinopathy injection
23 February 2009
FDA sets PDUFA date for Zogenix' Sumavel
23 February 2009
Teva profit down 67% on Barr merger costs
23 February 2009
Cubist told of Teva ANDA submission for Cubicin
16 February 2009
J&J seeking to enlarge paliperidone franchise
16 February 2009
Teva's Copaxone cleared in EU as preventative treatment
9 February 2009
Enrollment complete in Auxilium's Ph IIb Peyronie's trial
9 February 2009
Anakinra RA benefit comes at high risk
26 January 2009
Mg cuts cerebral palsy risk in pre-term babies
26 January 2009
APP debuts generic Zemuron in USA
26 January 2009
Javelin signs $71M deal on Dyloject
26 January 2009
ReNeuron gets nod for stem cell stroke trial
26 January 2009
Novartis drug slows 69% of GI tumors
26 January 2009
Bangladesh children to be vaccinated
26 January 2009
Celgene reports initial 2008 figures
26 January 2009
Algeta hails results of Alpharadin trial
19 January 2009
Prism gets FDA app for Nexterone injection
19 January 2009
China Biologics gets first sales order from India
15 January 2009
Halozyme gets $5.5M Baxter payment
12 January 2009
Oncolytics completes Reolysin enrollment in two trials
12 January 2009
King Pharma files CorVue NDA with FDA
12 January 2009
Medarex gets milestone from Centocor for Stelara
22 December 2008
Eisai anesthetic approved by FDA
22 December 2008
Mozobil appro for stem cell transplantation
22 December 2008
J&J's Doxil plus docetaxel improves TTP
22 December 2008
Genta appeals FDA's Genasense decision
22 December 2008
J&J's paliperidone LA shows 13-week control
22 December 2008
Lilly expects to report loss for full-year 2008 but 2009 guidance unaffected by forex
22 December 2008
Zosano complete end-of-Ph II ZP-PTH meeting with FDA
15 December 2008
FDA panel backs Genzyme's Synvisc-One for OA pain
15 December 2008
High activity for Vidaza/Revlimid combo in Ph I MDS study
15 December 2008
FDA review of wider Byetta label delayed
15 December 2008
Anika fully enrolled for Monovisc OA study
15 December 2008
Ono's interim results hit by NHI price cuts
8 December 2008
Strong Ph III for Relistor in non-cancer OIC
8 December 2008
Ortho Biotech files trabectedin NDA
1 December 2008
Progenics gets Australian appro for Relistor
24 November 2008
United Therapeutics plunges 33% as oral PAH drug misses Ph III endpoint, filing delay likely
24 November 2008
Ph IIb microplasmin trials promising
24 November 2008
US FDA accepts Debiopharm's Trelstar NDA for filing
24 November 2008
Sale of Ratiopharm being considered?
24 November 2008
GenVac gets FDA Fast Track for TNFerade
17 November 2008
S-P UK launches Bridion on local market
17 November 2008
Duska and DSM in manufacturing accord
17 November 2008
CV's 3rd-qtr 2008 loss narrows 26% to $25.4M
17 November 2008
Celgene's 3rd-qtr profit triples on drug sales
17 November 2008
Amylin shares plunge 26% on possible Byetta LAR US approval delay
10 November 2008
Vical gets US military contract for Dengue vacc
10 November 2008
FDA clears Akorn's ANDA for adenosine inj
10 November 2008
China Sky One gets two product approvals
10 November 2008
Merck KGaA submits sNDA in Japan for Gonal-f
3 November 2008
Nabi reports final smoking vaccine data
3 November 2008
FDA clears Sanofi's Apidra for children
3 November 2008
Novartis drug shows strong data in SJIA/CAPS
3 November 2008
Genzyme's 3rd-qtr 2008 profit down 25%
3 November 2008
Amylin hits 6-year low on Byetta LAR concerns
3 November 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
